BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32264626)

  • 1. Stimuli-responsive delivery vehicles based on mesoporous silica nanoparticles: recent advances and challenges.
    Zhu J; Niu Y; Li Y; Gong Y; Shi H; Huo Q; Liu Y; Xu Q
    J Mater Chem B; 2017 Feb; 5(7):1339-1352. PubMed ID: 32264626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
    Hu JJ; Xiao D; Zhang XZ
    Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-infrared light triggered drug release from mesoporous silica nanoparticles.
    Zhao T; Chen L; Li Q; Li X
    J Mater Chem B; 2018 Nov; 6(44):7112-7121. PubMed ID: 32254627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive functionalized mesoporous silica nanoparticles for drug release in response to various biological stimuli.
    Chen X; Cheng X; Soeriyadi AH; Sagnella SM; Lu X; Scott JA; Lowe SB; Kavallaris M; Gooding JJ
    Biomater Sci; 2014 Jan; 2(1):121-130. PubMed ID: 32481814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.
    Lai J; Shah BP; Zhang Y; Yang L; Lee KB
    ACS Nano; 2015 May; 9(5):5234-45. PubMed ID: 25859611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems.
    Wen J; Yang K; Liu F; Li H; Xu Y; Sun S
    Chem Soc Rev; 2017 Oct; 46(19):6024-6045. PubMed ID: 28848978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
    Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
    Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the stimuli-responsive mesoporous silica nanoparticles as drug delivery system nanotechnology for controlled release and cancer therapy.
    Zhu Y; Bai Y; He J; Qiu X
    3 Biotech; 2023 Aug; 13(8):274. PubMed ID: 37457870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-Responsive Silica Silanol Conjugates: Strategic Nanoarchitectonics in Targeted Drug Delivery.
    Mohanan S; Guan X; Liang M; Karakoti A; Vinu A
    Small; 2023 Mar; ():e2301113. PubMed ID: 36967548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticles as a drug delivery mechanism.
    Zhang W; Liu H; Qiu X; Zuo F; Wang B
    Open Life Sci; 2024; 19(1):20220867. PubMed ID: 38756857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
    Baeza A; Manzano M; Colilla M; Vallet-Regí M
    Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive nano-assemblies for remotely controlled drug delivery.
    Li F; Qin Y; Lee J; Liao H; Wang N; Davis TP; Qiao R; Ling D
    J Control Release; 2020 Jun; 322():566-592. PubMed ID: 32276006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.